Skip to main content
NCBI home page
The Journal of Hygiene logoLink to The Journal of Hygiene
. 1976 Aug;77(1):85–91. doi: 10.1017/s0022172400055546

Prevalent serotypes of Bordetella pertussis in non-vaccinated communities.

N W Preston
PMCID: PMC2129724  PMID: 185285

Abstract

In many countries, the prevalent serotypes of Bordetella pertussis have changed from a mixture of types 1,2,3 and 1,2 (organisms possessing antigen 2) to a predominance of type 1,3. The timing of the change in different countries is shown to be related to the introduction of mass-vaccination with material rich in antigens 1 and 2 but weak in, or devoid of, antigen 3. In several parts of the world, there have been outbreaks of type 1,3 infection in fully vaccinated children. Non-vaccinated communities in various parts of the world still show the pattern of serotypes which existed elsewhere before mass-vaccination. In order to avoid the disappointments experienced in the past, it is essential that pertussis vaccine for use in previously non-vaccinated communities, like that for any other country, should be rich in each of the three antigens.

Full text

PDF
85

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANDERSEN E. K. Serological studies on H. pertussis H. parapertussis and H. bronchisepticus. Acta Pathol Microbiol Scand. 1953;33(2):202–224. doi: 10.1111/j.1699-0463.1953.tb01512.x. [DOI] [PubMed] [Google Scholar]
  2. Aftandelians R. V., Connor J. D. Bordetella pertussis serotypes in a whooping cough outbreak. Am J Epidemiol. 1974 May;99(5):343–346. doi: 10.1093/oxfordjournals.aje.a121619. [DOI] [PubMed] [Google Scholar]
  3. Agarwal K. C., Preston N. W. Pertussis agglutinins in vaccinated mice : difficulty in estimating the type-specific response. Indian J Med Res. 1976 Mar;64(3):393–398. [PubMed] [Google Scholar]
  4. Blaskett A. C., Gulasekharam J., Fulton L. C. The occurrence of Bordetella pertussis serotypes in Australia, 1950-1970. Med J Aust. 1971 Apr 10;1(15):781–784. doi: 10.5694/j.1326-5377.1971.tb87864.x. [DOI] [PubMed] [Google Scholar]
  5. Eldering G., Holwerda J., Davis A., Baker J. Bordetella pertussis serotypes in the United States. Appl Microbiol. 1969 Oct;18(4):618–621. doi: 10.1128/am.18.4.618-621.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. LACEY B. W. Antigenic modulation of Bordetella pertussis. J Hyg (Lond) 1960 Mar;58:57–93. doi: 10.1017/s0022172400038134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. PRESTON N. W. EFFECTIVENESS OF PERTUSSIS VACCINES. Br Med J. 1965 Jul 3;2(5452):11–13. doi: 10.1136/bmj.2.5452.11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. PRESTON N. W. TYPE-SPECIFIC IMMUNITY AGAINST WHOOPING-COUGH. Br Med J. 1963 Sep 21;2(5359):724–726. doi: 10.1136/bmj.2.5359.724. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Perkins F. T. Vaccination against whooping-cough. Br Med J. 1969 Nov 15;4(5680):429–430. doi: 10.1136/bmj.4.5680.429. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Preston N. W. Efficacy of whooping-cough vaccines. Br Med J. 1973 May 26;2(5864):485–486. doi: 10.1136/bmj.2.5864.485-c. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Preston N. W., Mackay R. I., Bamford F. N., Crofts J. E., Burland W. L. Pertussis agglutinins in vaccinated children: better response with adjuvant. J Hyg (Lond) 1974 Aug;73(1):119–125. doi: 10.1017/s0022172400023913. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Preston N. W. Protection by pertussis vaccine. Little cause for concern. Lancet. 1976 May 15;1(7968):1065–1067. doi: 10.1016/s0140-6736(76)92234-0. [DOI] [PubMed] [Google Scholar]
  14. Preston N. W., Stanbridge T. N. Mouse or man? Which are pertussis vaccines to protect? J Hyg (Lond) 1976 Apr;76(2):249–256. doi: 10.1017/s0022172400055145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Preston N. W. Technical problems in the laboratory diagnosis and prevention of whooping-cough. Lab Pract. 1970 May;19(5):482–486. [PubMed] [Google Scholar]
  16. Shmilovitz M., Preston N. W., Zaltser H., Cahana A. Whooping cough in northern Israel. Isr J Med Sci. 1972 Dec;8(12):1936–1939. [PubMed] [Google Scholar]
  17. Stanbridge T. N., Preston N. W. Experimental pertussis infection in the marmoset: type specificity of active immunity. J Hyg (Lond) 1974 Apr;72(2):213–228. doi: 10.1017/s0022172400023421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Stanbridge T. N., Preston N. W. Variation of serotype in strains of Bordetella pertussis. J Hyg (Lond) 1974 Oct;73(2):305–310. doi: 10.1017/s0022172400024165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Walter T. Zum Problem der Keuchhustenimpfungen. Zentralbl Bakteriol Orig. 1968 Feb;206(1):131–132. [PubMed] [Google Scholar]

Articles from The Journal of Hygiene are provided here courtesy of Cambridge University Press

RESOURCES